Safety of probiotics: Translocation and infection

Nutrition Reviews

Volumn 66, Issue 4, 2008, Pages 192-202

  Liong, Min Tze ^a  

^a Universiti Sains Malaysia   (Malaysia)

Author keywords

GRAS; Infection; Probiotic; Translocation

Indexed keywords

PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BIFIDOBACTERIUM; ENTEROCOCCUS; FOOD COMPOSITION; FOOD SAFETY; HUMAN; IMMUNE DEFICIENCY; INFECTION; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LEUCONOSTOC; NONHUMAN; PEDIOCOCCUS; PEDIOCOCCUS ACIDILACTICI; REVIEW; RISK BENEFIT ANALYSIS;

BACTERIAL INFECTIONS; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM; ENTEROCOCCUS; HUMANS; IMMUNOCOMPROMISED HOST; INFECTION CONTROL; LACTOBACILLUS; PEDIOCOCCUS; PROBIOTICS; RISK ASSESSMENT; SAFETY;

BIFIDOBACTERIUM; ENTEROCOCCUS; LACTOBACILLUS; LEUCONOSTOC; PEDIOCOCCUS;

EID: 43449128102     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00024.x     Document Type: Review

References (67)

1. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003 4 : 658 672.
2. McFarland L. A review of evidences of health claims for biotherapeutic agents. Microb Ecol Health Dis 2000 12 : 65 76.
3. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Jarvinen A. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004 38 : 62 69.
4. Kullisaar T, Songisepp E, Mikelsaar M, Zilmer K, Vihalemm T, Zilmer M. Antioxidative probiotic fermented goats' milk decreases oxidative stress-mediated atherogenicity in human. Br J Nutr 2003 90 : 449 456.
5. Liong MT, Dunshea FR, Shah NP. Effects of a synbiotic containing Lactobacillus acidophilus ATCC 4962 on plasma lipid profiles and morphology of erythrocytes in hypercholesterolaemic pigs on high- and low-fat diets. Br J Nutr 2007 98 : 736 744.
6. Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Instr Pasteur 1994 92 : 45 67.
7. Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995 3 : 149 154.
8. Shou J, Motyka LE, Daly JM. Intestinal microbial translocation: immunologic consequences and effects of interleukin-4. Surgery 1994 116 : 868 876.
9. Berg RD. Translocation and the indigenous gut flora. In : Fuller R, ed. Probiotics: The Scientific Basis. London : Chapman & Hall 1992 : 55 85.
10. Rodriguez AV, Baigorí MD, Alvarez S, Castro GR, Oliver G. Phosphatidylinositol-specific phospholipase C activity in Lactobacillus rhamnosus with capacity to translocate. FEMS Microbiol Lett 2001 204 : 33 38.
11. Pavan S, Desreumaux P, Mercenier A. Use of mouse model to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin Diagn Lab Immunol 2003 10 : 696 701.
12. Chiva M, Soriano G, Rochat I, Peralta C, Rochat F, Llovet T, Mirelis B, Schiffrin EJ, Guarner C, Balanzo J. Effect of Lactobacillus johnsnonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis. J Hepatol 2002 4 : 456 462.
13. Shu Q, Gill HS. Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20TM) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 2002 1 : 59 64.
14. Romond MB, Haddou Z, Mielcareck C, Romond C. Bifidobacteria and human health: regulatory effect of indigenous bacteria on Escherichia coli intestinal colonization. Anaerobe 1997 2 : 131 136.
15. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001 73 (Suppl 465 470.
16. Adawi D, Ahrne S, Molin G. Effects of different probiotic strains of Lactobacillus and Bifidobacterium on bacterial translocation and liver injury in an acute liver injury model. Int J Food Microbiol 2001 3 : 213 220.
17. Zhou JS, Shu Q, Ritherford KJ, Prasad J, Birtles MJ, Gopal PK, Gill HS. Acute oral toxicity and bacterial translocation studies on potentially probiotic strains of lactic acid bacteria. Food Chem Toxicol 2000 38 : 153 161.
18. Cabana MD, Shane AL, Chao C, Oliva-Hemker M. Probiotics in primary care pediatrics. Clin Pediatr 2006 45 : 405 410.
19. Duc LH, Hong HA, Fairweather N, Ricca E, Cutting SM. Bacterial spores as vaccine vehicles. Infect Immun 2003 71 : 2810 2818.
20. Food and Drug Administration. Guidance for Industry on Complementary and Alternative Medicine Products and Their Regulation by the Food and Drug Administration. U.S. Department of Health and Human Services. 2006. Available at: http://www.fda.gov/CBER/gdlns/altmed.pdf. Accessed 10 February 2008.
21. Food and Drug Administration. Agency Response Letter GRAS Notice No. GRN 000171. U.S. Department of Health and Human Services. 2005. Available at: http://www.cfsan.fda.gov/∼rdb/opa-g171.html. Accessed 10 February 2008.
22. Food and Drug Administration. Safe and Suitable Ingredients Used in the Production of Meat and Poultry Products. U.S. Department of Health and Human Services. 2007. Available at: http://209.85.175.104/search?q=cache:9wfWGcQWS4UJ: www.fsis.usda.gov/OPPDE/rdad/FSISDirectives/7120.1_Amend_8. pdf+%22Safe+and+Suitable+Ingredients+Used+in+the+Production+of+Meat+and+ Poultry+Products%22+lactobacillus+acidophilus+patties&hl=en&ct= clnk&cd=1. Accessed 14 February 2008.
23. Food and Agriculture Organization. Guidelines for the Evaluation of Probiotics in Food 2002. Available at: ftp://ftp.fao.org/es/esn/food/wgreport2. pdf. Accessed 14 February 2008.
24. Burton, JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. Safety assessment of the oral cavity probiotic Streptococcus salivarius K12. Appl Environ Microbiol 2006 72 : 3050 3053.
25. Adams MR, Marteau, P. On the safety of lactic acid bacteria from food. Int J Food Microbiol 1995 27 : 263 264.
26. Huang Y, Kotula L, Adams MC. The in-vivo assessment of safety and gastrointestinal survival of an orally administered novel probiotic, Propionibacterium jensenii 702, in a male Wistar rat model. Food Chem Toxicol 2003 41 : 1781 1787.
27. Shu Q, Zhou JS, Rutherfurd KJ, Birtles MJ, Prasad J, Gopal PK, Gill HS. Probiotic lactic acid bacteria (Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019) have no adverse effects on health of mice. Int Dairy J 1999 9 : 831 836.
28. Zhou JS, Shu Q, Ritherford KJ, Prasad J, Birtles MJ, Gopal PK, Gill HS. Safety assessment of potential probiotic lactic acid bacteria strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017 and Bifidobacterium lactis HN019 in BALB/c mice. Int J Food Microbiol 2000 1 : 87 96.
29. Asahara T, Takahashi M, Nomoto K, Takayama H, Onoue M, Morotomi M, Tanaka R, Yokokura T, Yamashita N. Assessment of safety of lactobacillus strains based on resistance to host innate defense mechanisms. Clin Diagn Lab Immunol 2003 10 : 169 173.
30. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in the gnotobiotic mouse model. Infect Immunol 1979 23 : 401 411.
31. Perdigon G, Alvarez S, Aquero G, Medici M, Ruiz Holgado AP. Interactions between lactic acid bacteria, intestinal microflora and the immune system. In : Martins MT, Zanoli Sato MI, Tiedje JM, Norton Haggler JB, Dobereiner J, Sanchez P, eds. Proceedings of the 7th International Symposium of Microbial Ecology. Santos, Brazil 1997 : 311 316.
32. Duffy LD. Interactions mediating bacterial translocation in the immature intestine. J Nutr 2000 130 (Suppl 432 436.
33. Veltrop MHAM, Bancsi MJLM, Bertina RM, Thompson J. Role of monocytes in experimental Staphylococcus aureus endocarditis. Infect Immun 2000 68 : 4818 4821.
34. Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J Immunol 1993 150 : 888 895.
35. Schlegel L, Lemerle S, Geslin P. Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1998 17 : 887 888.
36. Berg RD. Translocation of enteric bacteria in health and disease. Curr Studies Hematol Blood Transfusion 1992 59 : 44 65.
37. Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis 2005 24 : 31 40.
38. Husni RN, Gordon SM, Washington JA, Longworth, DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis 1997 25 : 1048 1055.
39. Ze-Ze L, Tenreiro R, Duarte A, et al. Case of aortic endocarditis caused by Lactobacillus casei. J Med Microbiol 2004 53 : 451 453.
40. Makaryus AN, Yang R, Hahn RT, Kort S. A rare case of Lactobacillus acidophilus presenting as mitral valve bacterial endocarditis. Echocardiography 2005 22 : 421 425.
41. MacGregor G, Smith AJ, Thakker B, Kinsella J. Yoghurt biotherapy: contraindicated in immunosuppressed patients? Postgrad Med J 2002 78 : 366 367.
42. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005 115 : 178 181.
43. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatric Gastroenterol Nutr 2004 38 : 457 458.
44. Avlami A, Kordossis T, Vrizidis N, Sipsas NV. Lactobacillus rhamnosus endocarditis complicating colonoscopy. J Infect 2001 42 : 283 285.
45. 2 production and antibiotic resistance and correlation with human clinical status. J Clin Microbiol 1999 37 : 729 733.
46. Majcher-Peszynska J, Heine W, Richter I, Eggers G, Mohr C. Persistent Lactobacillus casei subspecies rhamnosus bacteremia in a 14-year-old girl with acute myeloid leukemia. A case report. Klin Pediatr 1999 211 : 53 56.
47. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B. Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol 2006 72 : 5799 5805.
48. Harty DWS, Patrikakis M, Knox KW. Identification of Lactobacillus strains from patients with infective endocarditis and comparison of their surface-associated properties with those of other strains of the same species. Microb Ecol Health Dis 1993 6 : 191 201.
49. Harty DSW, Oakey HJ, Patrikakis M, Hume EBH, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol 1994 24 : 179 189
50. Harty DWS, Patrikakis M, Hume EBH, Oakey HJ, Knox KW. The aggregation of human platelets by Lactobacillus species. J Gen Appl Microbiol 1993 139 : 2945 2951.
51. Oakey HJ, Harty DWS, Know KW. Enzyme production by lactobacilli and the potential link with infective endocarditis. J Appl Bacteriol 1995 78 : 142 148.
52. Ruseler-Van Embden GH, Van Lieshout LMC, Gosselink MJ, Marteau P. Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins. Scand J Gastroenterol 1995 30 : 675 680.
53. Liong MT, Shah NP. Bile salt deconjugation and BSH activity of five bifidobacterial strains and their cholesterol co-precipitating properties. Food Res Int 2005 38 : 135 142.
54. Sartor RB. Probiotic therapy of intestinal inflammation and infections. Curr Opin Gastroenterol 2004 21 : 44 50.
55. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect 1999 5 : 290 292.
56. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin Infect Dis 1999 28 : 1159 1160.
57. Olano A, Chua J, Schroeder S, Minari A, La Salvia M, Hall G. Weissella confusa (Basonym: Lactobacillus confusus) bacteremia: a case report. J Clin Microbiol 2001 39 : 1604 1607.
58. Antony S, Stratton CW, Dummer JS. Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis 1996 23 : 773 778.
59. McNaught CE, Woodcock NP, MacFie J, Mitchell CJ. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002 51 : 827 831.
60. Wheeler RT, Kupiec M, Magnelli P, Abeijon C, Fink GR. A Saccharomyces cerevisiae mutant with increased virulence. Proc Nat Academy Sci USA 2003 100 : 2766 2770.
61. Hara K, Saito A, Hirota M. The analysis of background factors of pneumonia by opportunisticpathogens. J Japan Assoc Infect Dis 1986 60 : 1125 1132.
62. Ouwehand AC, Saxelin M, Salminen S. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis 2004 39 : 1858 1860.
63. Murray PR, Baron E, Jorgenson JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology Washington, DC : ASM Press 2003 : 857 869.
64. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruuta P, Sarna S, Valtonen V, Jarvinen A. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002 35 : 1155 1160.
65. Gallemore GH, Mohon RT, Ferguson DA. Lactobacillus fermentum endocarditis involving a native mitral valve. J Tenn Medical Assoc 1995 88 : 306 308.
66. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother 1990 34 : 543 549.
67. Bozdogan B, Galopin S, Leclercq R. Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii. Appl Environ Microbiol 2004 70 : 280 284.